HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dexin Kong Selected Research

hirsuteine

11/2022Growth Inhibitory and Pro-Apoptotic Effects of Hirsuteine in Chronic Myeloid Leukemia Cells through Targeting Sphingosine Kinase 1.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dexin Kong Research Topics

Disease

40Neoplasms (Cancer)
11/2022 - 10/2007
10BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2022 - 04/2004
9Leukemia
11/2022 - 01/2008
9Neoplasm Metastasis (Metastasis)
12/2021 - 01/2011
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2016
5Prostatic Neoplasms (Prostate Cancer)
12/2021 - 06/2013
5Inflammation (Inflammations)
01/2021 - 10/2007
5Carcinogenesis
01/2017 - 06/2010
3Hepatocellular Carcinoma (Hepatoma)
01/2018 - 01/2016
3Infections
01/2018 - 12/2013
3Type 2 Diabetes Mellitus (MODY)
01/2018 - 12/2015
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2022 - 05/2021
2Heart Failure
10/2021 - 01/2020
2Breast Neoplasms (Breast Cancer)
01/2021 - 04/2016
2Glioblastoma (Glioblastoma Multiforme)
01/2021 - 07/2014
2Tetraploidy
01/2020 - 03/2017
2Hypersensitivity (Allergy)
06/2019 - 12/2018
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
07/2018 - 06/2017
2Body Weight (Weight, Body)
01/2018 - 01/2017
2Asthma (Bronchial Asthma)
08/2017 - 01/2009
1Cardiovascular Diseases (Cardiovascular Disease)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Human Influenza (Influenza)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Ovarian Neoplasms (Ovarian Cancer)
01/2021
1Obesity
01/2021

Drug/Important Bio-Agent (IBA)

13Pharmaceutical PreparationsIBA
10/2021 - 09/2008
8ZSTK474IBA
01/2019 - 10/2007
8Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
11/2018 - 09/2008
6Antineoplastic Agents (Antineoplastics)IBA
01/2020 - 01/2016
5Protein Isoforms (Isoforms)IBA
05/2021 - 10/2007
5SesquiterpenesIBA
12/2017 - 04/2004
3TriterpenesIBA
01/2021 - 07/2014
3Immunoglobulin E (IgE)IBA
06/2019 - 08/2017
3idelalisibIBA
11/2018 - 12/2016
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2018 - 12/2015
3stellettin BIBA
04/2017 - 07/2014
3smenospongineIBA
01/2011 - 04/2004
2Mitogen-Activated Protein KinasesIBA
01/2022 - 01/2018
2Gefitinib (Iressa)FDA Link
01/2022 - 01/2021
2Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2019
2AntigensIBA
01/2022 - 06/2019
2NVP-BKM120IBA
11/2021 - 01/2021
2Phosphatidylinositols (Phosphatidylinositol)IBA
11/2021 - 01/2017
270-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA
10/2021 - 01/2018
2Digoxin (Digitek)FDA LinkGeneric
10/2021 - 01/2020
2Insulin (Novolin)FDA Link
05/2021 - 01/2018
2Biomarkers (Surrogate Marker)IBA
01/2021 - 08/2018
2matrigelIBA
01/2021 - 01/2021
2MicroRNAs (MicroRNA)IBA
01/2021 - 01/2021
2Chlorogenic AcidIBA
01/2020 - 03/2017
2Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 07/2018
2luteolin-7-glucosideIBA
01/2020 - 03/2017
2IntegrinsIBA
12/2019 - 08/2018
2ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2019 - 01/2018
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 03/2009
2Peptides (Polypeptides)IBA
01/2018 - 01/2018
2O-diacetylbritannilactone OIBA
12/2017 - 08/2017
2Phosphotransferases (Kinase)IBA
01/2017 - 06/2010
2TOR Serine-Threonine KinasesIBA
01/2017 - 01/2016
2Class I Phosphatidylinositol 3-KinasesIBA
01/2017 - 04/2016
2bcr-abl Fusion ProteinsIBA
12/2016 - 01/2016
2aaptamineIBA
01/2011 - 03/2006
2AlkaloidsIBA
03/2006 - 07/2004
1sphingosine kinaseIBA
11/2022
1hirsuteineIBA
11/2022
1trametinibIBA
01/2022
1EpitopesIBA
01/2022
1Influenza Vaccines (Influenza Vaccine)FDA Link
01/2022
1VaccinesIBA
01/2022
1Macrophage Colony-Stimulating FactorIBA
01/2022
1Amlodipine (Norvasc)FDA LinkGeneric
01/2022
1Therapeutic UsesIBA
01/2022
1Cadherins (E-Cadherin)IBA
12/2021
1Palmitic Acid (Hexadecanoic Acid)IBA
12/2021
1Fatty Acids (Saturated Fatty Acids)IBA
12/2021
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2021
1Small Interfering RNA (siRNA)IBA
05/2021
1Proteasome InhibitorsIBA
01/2021
1pyrazolanthroneIBA
01/2021
1benzyloxycarbonylleucyl-leucyl-leucine aldehydeIBA
01/2021
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2021
1rucaparibIBA
01/2021
1LeptinIBA
01/2021
1Chemokine ReceptorsIBA
01/2021
1LigandsIBA
01/2021
1CXC ChemokinesIBA
01/2021
1napabucasinIBA
01/2021
1Lansoprazole (Prevacid)FDA LinkGeneric
01/2021
1Stromal Interaction Molecule 1IBA
01/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2021
1Propranolol (Inderal)FDA LinkGeneric
01/2021
1AntagomirsIBA
01/2021
1celastrolIBA
01/2021

Therapy/Procedure

24Therapeutics
01/2022 - 09/2008
3Drug Therapy (Chemotherapy)
11/2022 - 01/2010
2Oral Administration
01/2019 - 11/2018
1Immunotherapy
01/2022
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2021